Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands
about
Genetic variation in CD83 and risks of cervical and vulvar cancers: a population-based case-control study.Clinical progression of high-grade cervical intraepithelial neoplasia: estimating the time to preclinical cervical cancer from doubly censored national registry data.Determinants of seropositivity among HPV-16/18 DNA positive young women.Prognostic value of histopathology and trends in cervical cancer: a SEER population studyPrevalence of human papillomavirus in archival samples obtained from patients with cervical pre-malignant and malignant lesions from Northeast Brazil.Epidemiology and genotype distribution of human papillomavirus (HPV) in Southwest China: a cross-sectional five years study in non-vaccinated women.Prospective study of human papillomavirus and risk of cervical adenocarcinomaConstruction of a full transcription map of human papillomavirus type 18 during productive viral infection.High concordance of results of testing for human papillomavirus in cervicovaginal samples collected by two methods, with comparison of a novel self-sampling device to a conventional endocervical brushHuman papillomavirus species-specific interaction with the basement membrane-resident non-heparan sulfate receptor.Human papillomavirus types by age in cervical cancer precursors: predominance of human papillomavirus 16 in young women.Inhibitors of differentiation-1 promotes nitrosopyrrolidine-induced transformation of HPV 16-immortalized cervical epithelial cell.HPV types, HIV and invasive cervical carcinoma risk in Kampala, Uganda: a case-control study.Prevalence and Distribution of High-Risk Genotypes of HPV in Women with Severe Cervical Lesions in Madrid, Spain: Importance of Detecting Genotype 16 and Other High-Risk Genotypes.Pilot study of a commercialized human papillomavirus (HPV) genotyping assay: comparison of HPV risk group to cytology and histology.HPV Type Distribution and Cervical Cytology among HIV-Positive Tanzanian and South African Women.Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage studyThe contribution of HPV18 to cervical cancer is underestimated using high-grade CIN as a measure of screening efficiency.Cervical cancer prevention--cervical screening: science in evolution.A comparison of linear array and hybrid capture 2 for detection of carcinogenic human papillomavirus and cervical precancer in ASCUS-LSIL triage study.Clinicopathological significance of atypical glandular cells on Pap smearCD83 polymorphisms and cervical cancer risk.Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases.Human papillomavirus testing and genotyping in cervical screening.Next-generation treatment strategies for human papillomavirus-related head and neck squamous cell carcinoma: where do we go?Human papillomavirus genotype distribution in cervical intraepithelial neoplasia grade 2/3 and invasive cervical cancer in Japanese women.Adenocarcinoma in situ and associated human papillomavirus type distribution observed in two clinical trials of a quadrivalent human papillomavirus vaccine.Genomic aberrations in cervical adenocarcinomas in Hong Kong Chinese women.High-risk human papillomavirus infection in different histological subtypes of renal cell carcinoma.Functional implication of sequence variation in the long control region and E2 gene among human papillomavirus type 18 variants.HPV-16, HPV-58, and HPV-33 are the most carcinogenic HPV genotypes in Southwestern China and their viral loads are associated with severity of premalignant lesions in the cervix.Evaluation of the performance of the novel PapilloCheck® HPV genotyping test by comparison with two other genotyping systems and the HC2 test'DURVIT': a phase-I trial of single low-dose durvalumab (Medi4736) IntraTumourally injected in cervical cancer: safety, toxicity and effect on the primary tumour- and lymph node microenvironment
P2860
Q30541935-B767797A-2847-4F68-A10D-3D0D1982A6B5Q30658080-61DC14FE-F2E9-4443-9981-23A155D0C6FCQ30986936-48C0AEB9-512E-4123-8577-04E8CA52B018Q33295075-842A371B-69AA-4B79-B9AD-1BA94883CF5DQ33551047-F609F0D4-D232-434E-82CA-366242BE4903Q33592432-16C91E7C-B0C3-487D-854C-29FF792AF3BFQ34091747-F084B912-92B7-4305-A590-668B369810DFQ34193290-D7E820CD-E898-4526-9F28-042B486FA4CAQ34720012-FA3816E9-DDFE-4219-9FFD-317FA3EA0A59Q34774775-D0269E67-26DE-436C-AEBD-E63EA8DC5DFDQ34959801-DCBE6C34-5653-47CF-A00A-C0D4192801B1Q35051556-F5E27A97-7F48-4642-A994-33EF455D95C5Q35121777-025F380D-6E78-418F-B913-B16FD0DC7E1AQ35203337-C194A081-F9EA-4D92-8B0F-8A286E4BCC46Q35220798-AF800109-CB34-4BB7-9FB3-506B2D06E47BQ36088657-03E5BF42-31D2-4815-9A30-21DB59C60535Q36423668-96EABAF0-5844-4F8E-84A0-767ED9F42BC9Q36610328-25BC14C1-E7D8-41BE-89BD-3A06254EC451Q37025594-6A6FD10D-3C31-4098-AAA4-499051C0196DQ37165122-4B2EC1CF-9258-45F3-815F-56D29959BF38Q37199899-55BE9905-FB46-4AAE-BCE6-FACA8EF189A4Q37368494-520B692B-E10C-4FE3-8020-03E39CA998DDQ37414728-88E26F2C-7AE8-4FE4-B284-E565E519F1BEQ37909359-F1A722B6-732C-4ECA-86C4-0B629A86E84AQ37943790-02C0F904-85A5-4737-AC4E-0080B72BB217Q39139886-A28CEE5B-D792-4D51-9E11-65460A13D3DCQ39827423-F4B1CB46-8301-4299-988E-7B6A8BC4FF9DQ41519401-7297813F-3E1E-4438-B9EF-D92632F81BB2Q42226942-F7BFE3EB-6419-4FED-AEFA-4B4CD90F00D6Q51741346-A4F7FFE1-0B50-46DA-8F87-2AC32B97B79CQ55211458-39D4FB30-26FF-43FB-A15B-5C484836E762Q58174349-ADF44A86-AE40-4434-B3A1-B246D3A37185Q58748531-ACDB28D8-2AA2-4932-869D-061E668196BA
P2860
Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Preferential risk of HPV16 for ...... al cytology in The Netherlands
@ast
Preferential risk of HPV16 for ...... al cytology in The Netherlands
@en
type
label
Preferential risk of HPV16 for ...... al cytology in The Netherlands
@ast
Preferential risk of HPV16 for ...... al cytology in The Netherlands
@en
prefLabel
Preferential risk of HPV16 for ...... al cytology in The Netherlands
@ast
Preferential risk of HPV16 for ...... al cytology in The Netherlands
@en
P2093
P2860
P356
P1476
Preferential risk of HPV16 for ...... al cytology in The Netherlands
@en
P2093
C J L M Meijer
F J van Kemenade
G D Zielinski
L Rozendaal
N W J Bulkmans
P J F Snijders
P2860
P2888
P304
P356
10.1038/SJ.BJC.6602915
P407
P577
2006-01-01T00:00:00Z